Bertrand Bourre

Risk of autoimmune diseases and human papilloma virus (HPV) vaccines: Six years of case-referent surveillance

Lamiae Grimaldi‐Bensouda, Michel Rossignol, Isabelle Kone‐Paut et al. · Journal of Autoimmunity · 2017 · 84 citations · Full text

Medicine, Immunology, Pediatrics +15

Disease Reactivation After Cessation of Disease-Modifying Therapy in Patients With Relapsing-Remitting Multiple Sclerosis

Izanne Roos, Charles B. Malpas, Emmanuelle Leray et al. · Neurology · 2022 · 46 citations · Full text

Medicine, Neurology, Disability Management +14

Delay from treatment start to full effect of immunotherapies for multiple sclerosis

Izanne Roos, Emmanuelle Leray, Federico Frascoli et al. · Brain · 2020 · 40 citations · Full text

Life Sciences, Immunology, Neurology +17

Relapses in Patients Treated with High-Dose Biotin for Progressive Multiple Sclerosis

Sophie Mathais, Xavier Moisset, Frédéric Taithe et al. · Neurotherapeutics · 2020 · 11 citations · Full text

Medicine, Clinical Sciences, Neurology +12

Efficacy and clinical outcomes of percutaneous treatments for trigeminal neuralgia secondary to multiple sclerosis

Mathieu Lozouet, Elisabeth Garrido, Bertrand Bourre et al. · Clinical Neurology and Neurosurgery · 2024 · 10 citations

Medicine, Neurological Surgery, Neurology +13